Loading clinical trials...
Loading clinical trials...
Open Label Safety and Tolerability Trial of CPP-109 (Vigabatrin) in Adults With Treatment Refractory Tourette's Disorder
Conditions
Interventions
vigabatrin
Locations
1
United States
Tics and Tourette's Clinical and Research Program
New York, New York, United States
Start Date
July 1, 2012
Primary Completion Date
March 1, 2015
Completion Date
March 1, 2015
Last Updated
January 19, 2018
NCT01418339
NCT02864589
NCT01727713
NCT00706589
Lead Sponsor
Barbara J. Coffey
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions